Filing Details

Accession Number:
0001600620-23-000021
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-23 17:18:43
Reporting Period:
2023-05-18
Accepted Time:
2023-05-23 17:18:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600620 Aurinia Pharmaceuticals Inc. AUPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465278 P Joseph Hagan #140, 14315 ? 118 Avenue
Edmonton A0 T5L 4S6
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-18 8,733 $0.00 12,233 No 4 M Direct
Common Stock Disposition 2023-05-19 272 $10.58 11,961 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-05-18 8,733 $0.00 8,733 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-05-18 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
  2. Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.